Elisabetta Moratti CV (pdf, it, 34 KB, 5/3/10)

CURRICULUM VITAEELISABETTA MORATTI, PhD.PERSONAL DATA:Place and date of birth: Noale (VE), Italy, August 28th, 1980Contact information:University of Verona School of MedicineDepartment of PathologyGeneral Pathology SectionStrada Le Grazie, 837134 VeronaItalyPhone: +39 045 8027552Cell: +39 340 3790182Fax: +39 045 8027127elisabetta.moratti@univr.iteli.moratti@libero.itEDUCATION2007-2009 - PhD student in Human Oncological Pathology and Stem Cell Biology and ClinicalApplication at Graduate School in Translational Biomedicine, University of Verona School ofMedicine, Italy.2005 - 2 nd cycle degree (Master-level) in Sanitary biology (102/110) at University of Padova, Italy.2003 - 1 st cycle degree (Bachelor's level degree) in Molecular biology (98/110) at University ofPadova, Italy.LANGUAGE:Italian (native), English (Intermediate level: very good comprehension, fair level written andconversation)EMPLOYMENT EXPERIENCESeptember- December 2004: stage Erasmus project at Institut für Medizinische Psicologie,Arbeitsgruppe Chronobiologhie, “ Ludwig-Maximilians Universität München” .2006-present - Department of Pathology, General Pathology Section, Univ. of Verona

Expertise in several field of cell biology, biochemistry and molecular biology, including:− CELL BIOLOGY: cell culture (adherent and suspension cells), proliferation assays,clonogenic assays, use of antisense and siRNA .− BIOCHEMISTRY: Protein expression in eukariotic and prokariotic cells, proteinpurification, western blotting, immune-precipitation, phosphatase/kinase assays, ELISA,IHC Immunofluorescence and flow cytometry.− MOLECULAR BIOLOGY: RNA-DNA extraction and purification, cDNA mutagenesis andcloning, PCR, real-time PCR, in vitro transcription and translation, 5’RLM-RACE, SouthernBlotting.− Circadian Cycles Analysis in Neurospora crassa (race tube experiments).CONGRESS PARTECIPATIONS1. Della Peruta M, Mafficini A, Moratti E, Vezzalini M, Scarpa A, Laudanna C, Sorio C.Metastatic and non metastatic pancreatic cancer cell lines respond differentially to RhoAAND ζPKC inhibition. AISP - 31st National Congress. Naples (Italy). September 20-22,2007. J Pancreas (Online) 2007; 8(5 Suppl):656-657.2. Sorio C, Martinelli G, Monne M, Vezzalini M, Moratti E, Mafficini A, Della Peruta M.Down-regulation of protein tyrosine phosphatase gamma (PTPRG) in chronic myeloidleukemia (CML). 7th International Symposium on Target Anticancer Therapies.Amsterdam, March 23-25, 2009.3. Sorio C, Martinelli G, Monne M, Vezzalini M, Moratti E, Mafficini A, Della Peruta M.Down-regulation of protein tyrosine phosphatase gamma (PTPRG) in chronic myeloidleukemia (CML). Phosphorylation signaling & Disease, Cold spring Harbor, New York,May12-16, 2009.Full papers1) Marco Della Peruta, Giovanni Martinelli, Maria Monne, Davide Pintani, Tiziana Grafone, IlariaIacobucci, Simona Soverini, Marco Murineddu, Fabrizio Vinante, Cristina Tecchio, ElisabettaMoratti, Marzia Vezzalini, Giovanna Piras, Attilio Gabbas, Andrea Mafficini and Claudio Sorio

Protein tyrosine phosphatase receptor type gamma (PTPRG) is a functional tumor suppressor genespecifically down-regulated in chronic myeloid leukemia (CML), under revision2) Marzia Vezzalini, John M. Aletta, Stefania Beghelli, Elisabetta Moratti, Marco Della Peruta,Andrea Mafficini, Wilfrido D. Mojica, Aldo Mombello, Aldo Scarpa and Claudio SorioImmunohistochemical detection of arginine methylated proteins (MeRP) in archival tissues,Histopathology, accept.